Literature DB >> 19011632

Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation.

Victoria Marsh1, Douglas J Winton, Geraint T Williams, Nicole Dubois, Andreas Trumpp, Owen J Sansom, Alan R Clarke.   

Abstract

PTEN acts as a tumor suppressor in a range of tissue types and has been implicated in the regulation of intestinal stem cells. To study Pten function in the intestine, we used various conditional transgenic strategies to specifically delete Pten from the mouse intestinal epithelium. We show that Pten loss specifically within the adult or embryonic epithelial cell population does not affect the normal architecture or homeostasis of the epithelium. However, loss of Pten in the context of Apc deficiency accelerates tumorigenesis through increased activation of Akt, leading to rapid development of adenocarcinoma. We conclude that Pten is redundant in otherwise normal intestinal epithelium and epithelial stem cells but, in the context of activated Wnt signaling, suppresses progression to adenocarcinoma through modulation of activated Akt levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011632     DOI: 10.1038/ng.256

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  55 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Wnt signaling, stem cells, and cancer of the gastrointestinal tract.

Authors:  Arnout Schepers; Hans Clevers
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

3.  Radiofrequency ablation for dysplasia in Barrett's esophagus restores β-catenin activation within esophageal progenitor cells.

Authors:  K Krishnan; S Komanduri; J Cluley; R Dirisina; P Sinh; Jeff Z Ko; L Li; R B Katzman; T A Barrett
Journal:  Dig Dis Sci       Date:  2011-09-24       Impact factor: 3.199

4.  Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.

Authors:  Goo Lee; Tatiana Goretsky; Elizabeth Managlia; Ramanarao Dirisina; Ajay Pal Singh; Jeffrey B Brown; Randal May; Guang-Yu Yang; Josette William Ragheb; B Mark Evers; Christopher R Weber; Jerrold R Turner; Xi C He; Rebecca B Katzman; Linheng Li; Terrence A Barrett
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

5.  Intestinal epithelial-specific PTEN inactivation results in tumor formation.

Authors:  Do-Sun Byun; Naseem Ahmed; Shannon Nasser; Joongho Shin; Sheren Al-Obaidi; Sanjay Goel; Georgia A Corner; Andrew J Wilson; Dustin J Flanagan; David S Williams; Leonard H Augenlicht; Elizabeth Vincan; John M Mariadason
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 6.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

7.  Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis.

Authors:  Jeffrey B Brown; Goo Lee; Elizabeth Managlia; Gery R Grimm; Ramanarao Dirisina; Tatiana Goretsky; Paul Cheresh; Nichole R Blatner; Khashayarsha Khazaie; Guang-Yu Yang; Linheng Li; Terrence A Barrett
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

Review 8.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 9.  Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract.

Authors:  Jason C Mills; Owen J Sansom
Journal:  Sci Signal       Date:  2015-07-14       Impact factor: 8.192

10.  Prediction and testing of biological networks underlying intestinal cancer.

Authors:  Vishal N Patel; Gurkan Bebek; John M Mariadason; Donghai Wang; Leonard H Augenlicht; Mark R Chance
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.